2
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Ovarian Follicular Non-Hodgkins Lymphoma

, &
Pages 164-166 | Accepted 10 Aug 1990, Published online: 06 Jul 2009

References

  • Chorlton I, Norris H J, King F M. Malignant reticuloendothelial disease involving the ovary as a primary manifestation. Cancer 1974; 34: 397–402
  • Freeman C, Berg J W, Cutter S J. Occurrence and prognosis of extranodal lymphomas. Cancer 1972; 29: 252–60
  • Paladugu R R, Bearman R M, Rappaport H. Malignant lymphoma with primary manifestation in the gonad. Cancer 1980; 45: 561–71
  • Osborne B M, Robboy S J. Lymphomas or leukaemia presenting as ovarian tumours. Cancer 1983; 52: 1933–43
  • Nelson G A, Dockerty M B, Pratt J H, et al. Malignant lymphoma involving the ovaries. Am J Ob Gyn 1958; 76: 861–71
  • Rotmensch J, Woodruff J D. Lymphoma of the ovary: report of twenty new cases and update of previous series. Am J Ob Gyn 1982; 143: 870–5
  • Fox H, Langley F A. Tumours of the ovary. Heinemann, London 1976; 293–9
  • Halpin T F. Gynaecological implications of Burkitt's tumour. Obstetrical and Gynaecological Survey. 1975; 30: 351–8
  • Fox H, Langley F A, Govan A DT, et al. Malignant lymphoma presenting as an ovarian tumour: A clinicopathological analysis of 34 cases. Brit J of Ob Gynae. 1988; 95: 386–90
  • Gallagher C J, Lister T A. Follicular non-Hodgkins lymphoma. Balliere's Clinical Haematology, T J McElwain, T A Lister. Balliere and Tindall, London 1987; 1.1: 141–5
  • Paryani S B, Hoppe R T, Cox R S, et al. Analysis of non-Hodgkins lymphomas with nodular and favourable histologies, stages I and II. Cancer 1983; 52: 2300–7
  • Aisenberg A C, Wilkes B M, Long J C, et al. Cell surface phenotype in lymphoproliferative disorders. Am J Med 1980; 68: 206–13
  • Bloomfield C D, Kersey J H, Brunning R D, et al. Prognostic significance of lymphocyte surface markers in adult non-Hodgkins malignant lymphoma. Lancet 1976; 2: 1330–3
  • Rudders R A, DeLellis R A, Ahl E T. Adult non-Hodgkins lymphoma — correlation of cell surface marker phenotype with prognosis. Cancer 1983; 52: 2289–99

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.